Compare Jumia Technologies AG - ADR (JMIA) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jumia Technologies AG - ADR vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Jumia Technologies AG - ADR trades at $6.53 (market cap $900.64M), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Nuvation Bio Inc. Class A Common Stock is the larger of the two by market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, Jumia Technologies AG - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Jumia Technologies AG - ADR for 28 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| JMIA | NUVB | |
|---|---|---|
Market Cap | $900.64M | $1.71B |
Volume | 625,675 | 5,448,712 |
Sector | Consumer Cyclical | Health |
52-Week High | $14.60 | $9.54 |
52-Week Low | $5.69 | $3.41 |
Typical Hold Time | 28 Days | 0 Days |
Enterprise Value | $866.28M | $1.30B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JMIA trades at $6.48, down 4.71% today, with bearish technical signals from moving averages. The company shows improving fundamentals with revenue growth from $167M in 2024 to $189M in 2025 and narrowing losses, though it remains unprofitable with a -27.54% net margin. Recent news highlights a $50M capital raise and progress toward EBITDA breakeven by year-end 2026.
Analyst consensus is bullish with a $12 price target (71% buy ratings), but risks include persistent losses, high P/B ratio of 1,014, and negative cash flow from operations. The path to profitability and African market execution are critical for upside realization.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Jumia Technologies AG - ADR
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
